SelectQuote reported a revenue decline in Q1 FY27 but significantly narrowed its net and adjusted EBITDA losses. The company reaffirmed its full-year fiscal 2027 guidance, which could provide some stability for investors despite the top-line miss.
SelectQuote reported a revenue of $280.0 million for Q1 FY27, a decrease from $328.8 million in the prior year, indicating a top-line challenge. However, the company showed significant improvement in profitability, narrowing its net loss from $30.5 million to $20.3 million and its adjusted EBITDA loss from $32.1 million to $17.0 million. This suggests operational efficiencies or cost controls are taking effect. Management's reiteration of its full fiscal 2027 guidance, including revenue between $1.35 billion and $1.45 billion and adjusted EBITDA of $90 million to $115 million, is a key factor, as it implies confidence in future performance despite the current revenue dip. The SelectRx segment's improved profitability per member, despite a decline in total members, highlights a potential shift towards higher-value clients or better unit economics. For traders, the short-term impact might be mixed due to the revenue decline, but the reaffirmed guidance and improved profitability metrics could offer long-term stability, making SLQT a stock to watch for signs of sustained operational improvement.